[HTML][HTML] Multiethnic genome-wide and HLA association study of total serum IgE level

…, M Campbell, S Chavan, MH Cho, GL David… - Journal of Allergy and …, 2021 - Elsevier
Background Total serum IgE (tIgE) is an important intermediate phenotype of allergic
disease. Whole genome genetic association studies across ancestries may identify important …

Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors

…, S Chavan, G David, J Hanifin, MK Slifka… - Journal of Allergy and …, 2022 - Elsevier
Background While numerous genetic loci associated with atopic dermatitis (AD) have been
discovered, to date, work leveraging the combined burden of AD risk variants across the …

Improving investment behavior with pre-commitment

D Slifka - The Journal of Investing, 2013 - pm-research.com
In aggregate, investors succumb to human temptation to buy high and sell low. Academic
research on pre-commitment provides a framework for investors to support contrarian behavior …

Signaling sphingolipids are biomarkers for atopic dermatitis prone to disseminated viral infections

…, M Villarreal, K Johnson, G David, MK Slifka… - Journal of Allergy and …, 2022 - Elsevier
… Richers BS b , Patricia Taylor NP b , Lisa Beck MD c , Miguel Villarreal MS d , Keli Johnson
d , Gloria David PhD d , Mark K. Slifka PhD e , Jon Hanifin MD f , Donald YM Leung MD, PhD …

Transcutaneous yellow fever vaccination of subjects with or without atopic dermatitis

…, EL Simpson, S Tofte, S Baig-Lewis, G David… - Journal of allergy and …, 2014 - Elsevier
Background Atopic dermatitis (AD) is a common inflammatory skin disease with a global
prevalence ranging from 3% to 20%. Patients with AD have an increased risk for complications …

Why Most Limited Partners Should Avoid Catch-Ups

D Slifka - The Journal of Private Equity, 2012 - JSTOR
Private fond fee structures typically contain a catch-up—a widespread limited partner
preference—despite the fact that it increases fond fees and misaligns incentives. By estimating …

Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD4+ T cells and is quickly expressed on the cell surface in an antigen-specific manner

Y Koguchi, TJ Thauland, MK Slifka… - Blood, The Journal of …, 2007 - ashpublications.org
CD40 ligand (CD40L) is an essential effector cytokine for macrophage activation, dendritic
cell licensing, and T-cell–dependent antibody responses. Although CD40L is known to be …

Somos De Café: We Are Coffee

N Ptacek, D Slifka, A Vavra, A Carrow, B Essling… - 2008 - digitalcommons.csbsju.edu
After three students studied abroad to Guatemala in 2007 and witnessed firsthand the
importance of fair trade coffee to a healthy economy, they set out to make a 22-minute …

A Cell-Intrinsic Requirement for NF-κB–Inducing Kinase in CD4 and CD8 T Cell Memory

…, SE Murray, HP Raué, Y Koguchi, MK Slifka… - The Journal of …, 2013 - journals.aai.org
NF-κB–inducing kinase [(NIK), MAP3K14] is an essential kinase linking a subset of TNFR
family members to the noncanonical NF-κB pathway. To assess the cell-intrinsic role of NIK in …

[HTML][HTML] Preformed CD40L Is Stored in Th1, Th2, Th17, and T Follicular Helper Cells as Well as CD4+8 Thymocytes and Invariant NKT Cells but Not in Treg Cells

…, JL Gardell, ER Bivins-Smith, DB Jacoby, MK Slifka… - PloS one, 2012 - journals.plos.org
CD40L is essential for the development of adaptive immune responses. It is generally thought
that CD40L expression in CD4 + T cells is regulated transcriptionally and made from new …